Switzerland & United States — Food and Drug Administration
13 shared events · Importance 5 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Switzerland: Switzerland is the home country of key players Novartis and Roche, which are major participants in the market.
United States — Food and Drug Administration: The US FDA provides supportive regulatory frameworks that facilitate product approvals and market growth in North America.
Jul 28, 2026 · 6 articles
Tech
Switzerland: Allows psilocybin in limited contexts; results may influence its regulatory decisions.
United States — Food and Drug Administration: Regulatory body that may use these results to inform decisions on psychedelic therapies, potentially accelerating approvals.
Jul 30, 2026 · 6 articles
Business
Switzerland: Imlifidase is approved in Switzerland, indicating its presence in key European markets outside the EU.
United States — Food and Drug Administration: The United States — Food and Drug Administration accepted the Biologics License Application for imlifidase in February 2026, indicating potential future market expansion for the drug in the US.
May 27, 2026 · 6 articles
Business
Switzerland: Switzerland>>> is one of the regions where SERB Pharmaceuticals>>> will acquire rights to Imlifidase>>>.
United States — Food and Drug Administration: The United States — Food and Drug Administration>>> accepted the Biologics License Application for imlifidase in the US, indicating future market potential outside the current deal.
May 19, 2026 · 7 articles
Business
Switzerland: Switzerland is one of the countries where additional regulatory filings are planned for Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel.
United States — Food and Drug Administration: The United States — Food and Drug Administration has granted orphan drug designation and regenerative medicine advanced therapy (RMAT) designations to Allogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel.
Jun 10, 2026 · 6 articles
Business
Switzerland: Switzerland is one of the licensed territories where VISUfarma will commercialize YUVEZZI.
United States — Food and Drug Administration: The FDA's approval of YUVEZZI is a prerequisite for its U.S. commercialization and adds credibility to the product.
Aug 20, 2026 · 12 articles
Business
Switzerland: Switzerland is another market where Idefirix is approved, part of the product's global regulatory approvals.
United States — Food and Drug Administration: The FDA's acceptance of the BLA and PDUFA date of December 19, 2026, are key upcoming regulatory milestones for GT Biopharma in the US market.
Aug 18, 2026 · 6 articles
Tech
Switzerland: Imlifidase is approved in Switzerland, expanding its global reach.
United States — Food and Drug Administration: The United States — Food and Drug Administration accepted the Biologics License Application for imlifidase, setting a PDUFA action date for December 19, 2026.
May 25, 2026 · 6 articles
Business
Switzerland: Basilea is headquartered in Switzerland; no direct impact on the country.
United States — Food and Drug Administration: FDA granted Fast Track, Orphan Drug, and QIDP designations to fosmanogepix, facilitating its development.
Jul 29, 2026 · 6 articles
Domestic
Switzerland: Swiss authorities assisted in the cartel dismantlement, contributing to international drug enforcement.
United States — Food and Drug Administration: NAFDAC sent goodwill messages, showing inter-agency cooperation in drug control.
Jun 26, 2026 · 7 articles
Business
Switzerland: Switzerland is a member of the European Free Trade Association, with which India has implemented a trade pact.
United States — Food and Drug Administration: Indian generic medicines approved by the United States — Food and Drug Administration>>> will receive fast-track marketing authorization in Oman>>> under the CEPA.
May 29, 2026 · 79 articles
Tech
Switzerland: Garmin Enduro 3 Ltd. is incorporated in Switzerland, but the event has no direct impact on the country.
United States — Food and Drug Administration: The FDA cleared the Natural Cycles app, which integrates with the CIRQA Smart Band for reproductive health tracking.
Jul 21, 2026 · 6 articles
Business
Switzerland: Switzerland is the location of Altor BioScience' operations and the Capital Markets Day event.
Jun 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Switzerland and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard